11-7038738-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_176822.4(NLRP14):āc.152A>Gā(p.Lys51Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000852 in 1,614,126 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.0044 ( 8 hom., cov: 32)
Exomes š: 0.00048 ( 4 hom. )
Consequence
NLRP14
NM_176822.4 missense
NM_176822.4 missense
Scores
2
16
Clinical Significance
Conservation
PhyloP100: 3.72
Genes affected
NLRP14 (HGNC:22939): (NLR family pyrin domain containing 14) The protein encoded by this gene belongs to the NALP protein family. Members of the NALP protein family typically contain a NACHT domain, a NACHT-associated domain (NAD), a C-terminal leucine-rich repeat (LRR) region, and an N-terminal pyrin domain (PYD). This protein may play a regulatory role in the innate immune system as similar family members belong to the signal-induced multiprotein complex, the inflammasome, that activates the pro-inflammatory caspases, caspase-1 and caspase-5. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.007266909).
BP6
Variant 11-7038738-A-G is Benign according to our data. Variant chr11-7038738-A-G is described in ClinVar as [Benign]. Clinvar id is 3056667.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NLRP14 | NM_176822.4 | c.152A>G | p.Lys51Arg | missense_variant | 2/12 | ENST00000299481.5 | NP_789792.1 | |
NLRP14 | XM_011520044.2 | c.152A>G | p.Lys51Arg | missense_variant | 2/11 | XP_011518346.1 | ||
NLRP14 | XM_047426867.1 | c.152A>G | p.Lys51Arg | missense_variant | 2/11 | XP_047282823.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NLRP14 | ENST00000299481.5 | c.152A>G | p.Lys51Arg | missense_variant | 2/12 | 5 | NM_176822.4 | ENSP00000299481.5 |
Frequencies
GnomAD3 genomes AF: 0.00437 AC: 665AN: 152204Hom.: 8 Cov.: 32
GnomAD3 genomes
AF:
AC:
665
AN:
152204
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00130 AC: 325AN: 250948Hom.: 5 AF XY: 0.000973 AC XY: 132AN XY: 135720
GnomAD3 exomes
AF:
AC:
325
AN:
250948
Hom.:
AF XY:
AC XY:
132
AN XY:
135720
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000484 AC: 708AN: 1461804Hom.: 4 Cov.: 36 AF XY: 0.000468 AC XY: 340AN XY: 727216
GnomAD4 exome
AF:
AC:
708
AN:
1461804
Hom.:
Cov.:
36
AF XY:
AC XY:
340
AN XY:
727216
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00438 AC: 667AN: 152322Hom.: 8 Cov.: 32 AF XY: 0.00442 AC XY: 329AN XY: 74482
GnomAD4 genome
AF:
AC:
667
AN:
152322
Hom.:
Cov.:
32
AF XY:
AC XY:
329
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
53
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
186
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
NLRP14-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 13, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at